Venture Capital Industry News
A collection of Venture Capital latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
IBM's head of venture capital shares the 5 'pillars' she considers when deciding to back a startup
Emily Fontaine engages with VC firms, startups, and portfolio companies every day, she told Business Insider, and she knows what she wants from them. As IBM's global head of venture capital, Fontaine leads IBM Ventures, which partners with…

Editorial | Top UN ranking proves the benefits of Hong Kong's integration
Hong Kong has been accelerating its integration into the Greater Bay Area, China's key engine of growth. That has borne fruit for the city's increased productivity and innovation. Our joint efforts are now being internationally recognised by the…

Shenzhen-Hong Kong-Guangzhou named the world's top innovation hub
Innovative technology is undeniably integral to daily life in the 21st century, and cities around the world are locked in a competitive battle to rise to the forefront of this rat race. Global innovation clusters driving research, inventions, and…

India's online gaming ban might drive addicts underground
By Annie Banerji / Reuters, NEW DELHI India's ban of online money-based games could drive addicts to unregulated apps and offshore platforms that pose new financial and social risks, fantasy-sports gaming experts say. Indian Prime Minister Narendra…

Sebi Eases Large Trusted FPIs Entry, Lowers MF Exit Load To Max 3 %, Reclassifies REITs As Equity
Sebi Board approved introduction of Single Window Automatic & Generalised Access for Trusted Foreign Investors (SWAGAT-FI) framework for FPIs and Foreign Venture Capital Investors (FVCIs) to facilitate easier investment access for objectively…

Tunisia's Addvocate.AI Secures Investment to Boost Sales Tech Expansion
Addvocate.AI, a Tunisia- and France-based startup, has raised funding from venture firm 216 Capital to accelerate product development and global expansion. The investment amount was not disclosed. Founded in 2024 by Ridha Mami and Sofyan Chekir…

Should we raise capital via debt or equity?
Amid a financing drought, should business leaders bet on debt or dilute with equity? Himanshu Singh gives us his take Nearly half of UK SMEs have paused trading in the last two years as they become victims of a financing drought at the very moment…

The AI Bubble Is About To Burst, But The Next Bubble Is Already Growing
Speculation rules the world. It didn't used to. But from the 1980s through to 2008, something changed. Investors realised that they could get far more return from hype than from any kind of legitimate business. This is the information age, after…

Rising Prices, Rentals, And Affordable Home Shortages: How Are Homebuyers Struggling In India?
New Delhi: Home prices in India are rising faster than expected, driven by strong demand from affluent buyers, while a shortage of affordable housing is keeping many urban residents confined to expensive rental options, according to a recent…

Why California backed off again from ambitious AI regulation
A bill mandating disclosure and appeals for a wide range of AI decisions was delayed until next year for the third legislative session in a row. Gov. Gavin Newsom is expected to consult on the measure. After three years of trying to give…

Nearly half of IPO-bound Indian start-ups are loss-making
What's the story In a year of high public market activity, nearly half of the Indian start-ups eyeing an IPO are still in the red. Out of 42 companies that either filed their draft red herring prospectuses with SEBI or are preparing to do so, 21…

A Low-Budget Box Office Juggernaut Spawned The Conjuring Cinematic Universe
(Welcome to Tales from the Box Office, our column that examines box office miracles, disasters, and everything in between, as well as what we can learn from them.) 'Everyone's had dolls, and toys, and things growing up, and you associate those with…

Why Merck and AstraZeneca may regret turning their back on Britain
Two shock events rocked Britain's life sciences sector last week. First, the US company Merck slammed the brakes on a £1 billion London research centre. Then AstraZeneca, the FTSE 100 giant, said it would pause a £200 million investment…
Receive a Daily briefing on Venture Capital Industry News
Get Started